40. Takayasu arteritis Clinical trials / Disease details


Clinical trials : 25 Drugs : 50 - (DrugBank : 21) / Drug target genes : 25 - Drug target pathways : 114

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05151848
(ClinicalTrials.gov)
January 5, 20226/11/2021Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu ArteritisAn Open-label,Randomized, Controlled, Multicenter Study of Adalimumab and Tofacitinib in the Treatment of Active Takayasu ArteritisTakayasu ArteritisDrug: Adalimumab Injection;Drug: Tofacitinib 5 MGChinese SLE Treatment And Research GroupNULLRecruiting18 Years65 YearsAll100Phase 4China